PD-1 expression on tumor-specific T cells: Friend or foe for immunotherapy?

Sylvain Simon; Nathalie Labarrière

doi:10.1080/2162402x.2017.1364828

Journal Articles OncoImmunology Year : 2017

PD-1 expression on tumor-specific T cells: Friend or foe for immunotherapy?

(1, 2) , (1, 2)

1
2

Sylvain Simon

Function : Author

LabEX IGO Immunothérapie Grand Ouest

Anti-Tumor Immunosurveillance and Immunotherapy

Nathalie Labarrière

Function : Author
PersonId : 182569
IdHAL : nathalie-labarriere
ORCID : 0000-0002-1407-6546
IdRef : 127025154

LabEX IGO Immunothérapie Grand Ouest

Anti-Tumor Immunosurveillance and Immunotherapy

Domains

Life Sciences [q-bio] Immunology Life Sciences [q-bio] Immunology Immunotherapy Life Sciences [q-bio] Cancer

Fichier principal

ArtEq3SimonLabarriere.pdf (2.85 Mo)

Origin : Publication funded by an institution

Elizabeth Bernardo : Connect in order to contact the contributor

https://www.hal.inserm.fr/inserm-01592666

Submitted on : Monday, September 25, 2017-11:42:45 AM

Last modification on : Wednesday, February 8, 2023-5:11:02 PM

Dates and versions

inserm-01592666 , version 1 (25-09-2017)

Identifiers

HAL Id : inserm-01592666 , version 1
DOI : 10.1080/2162402x.2017.1364828

Cite

Sylvain Simon, Nathalie Labarrière. PD-1 expression on tumor-specific T cells: Friend or foe for immunotherapy?. OncoImmunology, In press, 7 (1), pp.e1364828. ⟨10.1080/2162402x.2017.1364828⟩. ⟨inserm-01592666⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

INSERM UNIV-NANTES CNRS UNIV-ANGERS CRCINA ANR INCIT NANTES-UNIVERSITE

178 View

122 Download

PD-1 expression on tumor-specific T cells: Friend or foe for immunotherapy?

Domains

Dates and versions

Identifiers

Cite

Export

Collections

Altmetric

Share